01349.HK
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.37
−0.21%Margins
Gross margin
87.3%
EBITDA margin
-8.6%
EBIT margin
-19.5%
Net margin
-18.7%
FCF margin
21.5%
-5.8%
Return on equity
-5.1%
Return on assets
-6.0%
Return on invested capital
0.28x
Asset turnover
HKD 195.7M
Cash from operations
HKD 1.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026